Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum. ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
This patient support community is for discussions relating to cancer, cancer staging, chemotherapy, hormonal therapy, radiation therapy, surgery, and tumor types.
Mood: Heathermommytobe Is having Surgery in a week and is wondering if this will be her chance to have a child Journal Entry: "Well i had another ultra sound today and ..." [Read]
Likewise, small cell lung cancer or non-hodgkins lymphomas do not "result" from paraneoplastic syndromes. These cancers are already present at the onset of the syndrome, albeit in an occult (hidden) form.
Paraneoplastic syndromes usually result from one of the following mechanisms:
1. The tumor produces substances which exert hormone-like effects [example: small cell lung cancer producing adrenocorticotropic hormone (ACTH) or anti-diuretic hormone (ADH).]
2. Symptoms are produced as a result of "host response" to the tumor. Host response typically takes the form of production of antibodies to the tumor. These antibodies can cross-react with normal body tissue (example: neurons in the brain), resulting in the syndrome.
From the symptoms you described, I think your neurologist is considering the syndrome called paraneoplastic cerebellar degeneration (PCD). This syndrome happens when anti-tumor antibodies cross react with nerve cells in the cerebellum, causing dizziness, ataxia and nystagmus. To confirm this diagnosis, two things need to be done: 1) prove the existence of an underlying tumor by visualizing it using a radiographic procedure (preferably PET scan), and 2) detect the presence of circulating anti-tumor antibodies (called anti-Yo, anti-Hu and anti-Ri) in the cerebrospinal fluid or in the serum.